Travere Therapeutics Inc (NASDAQ:TVTX)

27.52
Delayed Data
As of Jan 14
 +1.63 / +6.30%
Today’s Change
12.75
Today|||52-Week Range
33.09
-11.34%
Year-to-Date
No recent news for Travere Therapeutics Inc.

Today’s Trading

Previous close25.89
Today’s open25.76
Day’s range25.41 - 27.61
Volume32,334
Average volume (3 months)592,783
Market cap$1.7B
Data as of 4:00pm ET, 01/14/2022

Growth & Valuation

Earnings growth (last year)-3.05%
Earnings growth (this year)+17.98%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+13.11%
P/E ratioNM
Price/Sales6.53
Price/Book6.81

Competitors

----
PTGXProtagonist Therapeu...+1.21+3.48%
MORFMorphic Holding Inc+2.60+6.18%
NSTGNanoString Technolog...+0.80+2.28%
Data as of 4:00pm ET, 01/14/2022

Financials

Next reporting dateMarch 1, 2022
EPS forecast (this quarter)-$0.72
Annual revenue (last year)$198.3M
Annual profit (last year)-$169.4M
Net profit margin-85.43%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts